EXO Biologics

TLDR

EXO Biologics develops therapeutic exosomes and extracellular vesicles as nanomedicine alternatives to stem cell therapies.

Overview

EXO Biologics focuses on extracellular vesicles (EVs) and exosomes as therapeutic messengers, positioning them as safer, more consistent, and more stable alternatives to cell-based approaches. The company operates a CDMO platform targeting rare inflammatory diseases with a focus on drug loading, delivery, and GMP manufacturing of exosomes derived from cultured human umbilical cord mesenchymal stromal cells.